ES2147320T3 - Derivados de n-(3-benzofuranil)urea. - Google Patents

Derivados de n-(3-benzofuranil)urea.

Info

Publication number
ES2147320T3
ES2147320T3 ES96102650T ES96102650T ES2147320T3 ES 2147320 T3 ES2147320 T3 ES 2147320T3 ES 96102650 T ES96102650 T ES 96102650T ES 96102650 T ES96102650 T ES 96102650T ES 2147320 T3 ES2147320 T3 ES 2147320T3
Authority
ES
Spain
Prior art keywords
urea
derivatives
benzofuranil
benzofurane
substitute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96102650T
Other languages
English (en)
Inventor
Gabriele Dr Braunlich
Rudiger Dr Fischer
Mazen Dr Es-Sayed
Rolf Dr Henning
Michael Dr Sperzel
Karl-Heinz Dr Schlemmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2147320T3 publication Critical patent/ES2147320T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)

Abstract

DERIVADOS DE UREA N-(3-BENZOFUENIL) SON PROPORCIONADOS POR REACCION DE BENZOFURANO SUSTITUTO 3-AMINO CON SUSTITUTO APROPIADO ISOCIONATOS Y ISOFIONATOS. LOS DERIVADOS-UREA -N(3-BENZOFURANO) PUEDEN SER USADOS COMO INGREDIENTES ACTIVOS EN MEDICAMENTOS PARTICULARES PARA EL TRATAMIENTO DE PROCESOS ANTIINFLAMATORIOS Y HONDA.
ES96102650T 1995-03-06 1996-02-22 Derivados de n-(3-benzofuranil)urea. Expired - Lifetime ES2147320T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504460.8A GB9504460D0 (en) 1995-03-06 1995-03-06 N-(3-Benzofuranyl)urea-derivatives

Publications (1)

Publication Number Publication Date
ES2147320T3 true ES2147320T3 (es) 2000-09-01

Family

ID=10770709

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96102650T Expired - Lifetime ES2147320T3 (es) 1995-03-06 1996-02-22 Derivados de n-(3-benzofuranil)urea.

Country Status (41)

Country Link
US (2) US6399657B1 (es)
EP (1) EP0731099B1 (es)
JP (1) JP3204901B2 (es)
KR (2) KR100405579B1 (es)
CN (2) CN1176651C (es)
AR (1) AR002710A1 (es)
AT (1) ATE193704T1 (es)
BG (2) BG100396A (es)
BR (1) BR9600930A (es)
CA (1) CA2170824A1 (es)
CO (1) CO4370145A1 (es)
CZ (1) CZ66796A3 (es)
DE (1) DE69608721T2 (es)
DK (1) DK0731099T3 (es)
DZ (1) DZ1998A1 (es)
EE (1) EE03921B1 (es)
ES (1) ES2147320T3 (es)
FI (1) FI960998A7 (es)
GB (1) GB9504460D0 (es)
GR (1) GR3034240T3 (es)
HR (1) HRP960071B1 (es)
HU (1) HU222282B1 (es)
IL (1) IL117349A (es)
MA (1) MA23815A1 (es)
MY (1) MY117526A (es)
NO (1) NO313672B1 (es)
NZ (1) NZ286107A (es)
PE (1) PE43597A1 (es)
PL (1) PL189206B1 (es)
PT (1) PT731099E (es)
RO (1) RO116622B1 (es)
RU (1) RU2162845C2 (es)
SI (1) SI0731099T1 (es)
SK (1) SK281817B6 (es)
SV (1) SV1996000015A (es)
TN (1) TNSN96035A1 (es)
TR (1) TR199600177A2 (es)
TW (1) TW336934B (es)
UA (1) UA46714C2 (es)
YU (1) YU49359B (es)
ZA (1) ZA961774B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
JPH10168095A (ja) 1996-12-10 1998-06-23 Cci Corp 炎症性腸疾患予防および治療剤
JP2002529444A (ja) * 1998-11-12 2002-09-10 アリアド・ファーマシューティカルズ・インコーポレイテッド 二環式シグナル伝達阻害剤、それを含む組成物とその用途
GB2350109A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofuranyl sulfonates
GB2350110A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active benzofurans
GB2350112A (en) * 1999-05-17 2000-11-22 Bayer Ag Pharmaceutically active cycloalkyl ketones
GB2350111A (en) * 1999-05-17 2000-11-22 Bayer Ag Oligohydroxyl substituted 3-urea-benzofuran and pyridofuran derivatives
CN1639146A (zh) * 2002-02-22 2005-07-13 拜尔药品公司 用于治疗过度增生疾病的稠合三环杂环
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
CN1738797A (zh) 2002-11-19 2006-02-22 阿基里昂药品公司 取代的芳基硫脲和相关的化合物,病毒复制的抑制剂
US7186725B2 (en) 2003-01-03 2007-03-06 Genzyme Corporation Anti-inflammatory compositions and methods
TW200528459A (en) * 2004-01-06 2005-09-01 Achillion Pharmaceuticals Inc Azabenzofuran substituted thioureas; inhibitors of viral replication
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
WO2006137350A1 (ja) * 2005-06-22 2006-12-28 Kissei Pharmaceutical Co., Ltd. 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
EP2359826B1 (en) 2006-07-05 2013-10-30 Takeda GmbH Combination of HMG-COA reductase inhibitor rosuvastatin with a phosphodiesterase 4 inhibitor, such as roflumilast, roflumilast-N-oxide for the treatment of inflammatory pulmonary diseases
WO2012123353A1 (en) 2011-03-17 2012-09-20 Algiax Pharmaceuticals Gmbh Novel use of benzofuranylsulfonates
WO2013156232A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of benzofuranylsulfonates in neuropathic pain
PL3119744T3 (pl) 2014-03-18 2019-07-31 Algiax Pharmaceuticals Gmbh Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
EP3165224A1 (en) 2015-11-09 2017-05-10 Albert-Ludwigs-Universität Freiburg Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
JP6788966B2 (ja) * 2015-12-24 2020-11-25 丸善製薬株式会社 化粧料
EP4020024A1 (en) 2020-12-22 2022-06-29 Paul Scherrer Institut Method for producing high aspect ratio fan-shaped optics

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1382742A (en) * 1972-09-19 1975-02-05 Labaz Benzofuran derivatives and process for preparing the same
GB1464242A (en) * 1974-04-18 1977-02-09 Smithkline Corp Benzoyl benzofurans and compositions comprising them
AU559687B2 (en) * 1981-07-01 1987-03-19 Upjohn Company, The Pyridinyl-and imidazolyl-benzofurane and benzothiophenes
US4933351A (en) * 1983-10-31 1990-06-12 Merck Frosst Canada, Inc. Benzofuran 2-carbox amides useful as inhibitors of leukoriene biosynthesis
US4822803A (en) * 1983-10-31 1989-04-18 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid hydrazides useful as inhibitors of leukotriene biosynthesis
US4663347A (en) 1983-10-31 1987-05-05 Merck Frosst Canada, Inc. Benzofuran 2-carboxylic acid esters useful as inhibitors of leukotriene biosynthesis
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US5087638A (en) * 1984-06-20 1992-02-11 Merck Frosst Canada, Inc. Benzofuran derivatives
US4703053A (en) * 1985-10-28 1987-10-27 Warner-Lambert Company Benzothiophenes and benzofurans and antiallergic use thereof
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives

Also Published As

Publication number Publication date
DZ1998A1 (fr) 2002-07-20
JP3204901B2 (ja) 2001-09-04
HRP960071A2 (en) 1997-12-31
HU9600549D0 (en) 1996-04-29
PL313070A1 (en) 1996-09-16
IL117349A0 (en) 1996-07-23
SV1996000015A (es) 1997-02-17
KR960034194A (ko) 1996-10-22
EP0731099A1 (en) 1996-09-11
TNSN96035A1 (fr) 2005-03-15
YU13396A (sh) 1999-06-15
RO116622B1 (ro) 2001-04-30
MY117526A (en) 2004-07-31
TW336934B (en) 1998-07-21
NO960884D0 (no) 1996-03-05
FI960998A0 (fi) 1996-03-04
ZA961774B (en) 1996-09-17
KR100438633B1 (ko) 2004-07-02
RU2162845C2 (ru) 2001-02-10
GB9504460D0 (en) 1995-04-26
DE69608721D1 (de) 2000-07-13
CO4370145A1 (es) 1996-10-07
ATE193704T1 (de) 2000-06-15
AU4582896A (en) 1996-09-19
BG62732B1 (bg) 2000-06-30
SK29796A3 (en) 1996-10-02
NO313672B1 (no) 2002-11-11
EE03921B1 (et) 2002-12-16
HK1013285A1 (en) 1999-08-20
CN1176651C (zh) 2004-11-24
HUP9600549A2 (en) 1997-07-28
HRP960071B1 (en) 2001-04-30
PT731099E (pt) 2000-11-30
US6677372B2 (en) 2004-01-13
UA46714C2 (uk) 2002-06-17
IL117349A (en) 2002-09-12
EP0731099B1 (en) 2000-06-07
EE9600030A (et) 1996-10-15
CN1313284A (zh) 2001-09-19
JPH08253466A (ja) 1996-10-01
DK0731099T3 (da) 2000-09-25
FI960998L (fi) 1996-09-07
AR002710A1 (es) 1998-04-29
NZ286107A (en) 1998-08-26
BR9600930A (pt) 1997-12-30
SK281817B6 (sk) 2001-08-06
TR199600177A2 (tr) 1996-10-21
CZ66796A3 (en) 1996-09-11
US20030109578A1 (en) 2003-06-12
DE69608721T2 (de) 2000-10-05
KR100405579B1 (ko) 2004-03-19
CA2170824A1 (en) 1996-09-07
BG100396A (bg) 1996-12-31
CN1134419A (zh) 1996-10-30
PE43597A1 (es) 1997-12-26
HU222282B1 (hu) 2003-05-28
AU705667B2 (en) 1999-05-27
FI960998A7 (fi) 1996-09-07
MA23815A1 (fr) 1996-10-01
US6399657B1 (en) 2002-06-04
SI0731099T1 (en) 2000-08-31
GR3034240T3 (en) 2000-12-29
YU49359B (sh) 2005-09-19
NO960884L (no) 1996-09-09
HUP9600549A3 (en) 1998-04-28
PL189206B1 (pl) 2005-07-29

Similar Documents

Publication Publication Date Title
ES2147320T3 (es) Derivados de n-(3-benzofuranil)urea.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
AR002289A1 (es) Derivados de acetamida, procedimiento para prepararlos, las composiciones farmaceuticas que los contienen y las aplicaciones de dichos compuestos comoansioliticos y en el tratamiento de enfermedades inmuno-inflamatorias.
ES2170884T3 (es) Acidos alfa-iminohidroxamicos y carboxilicos n-sustituidos, ciclicos y heterociclicos.
MX9308013A (es) 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen.
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
ES2149971T3 (es) Derivados 5-sustituidos del acido micofenolico.
AR007828A1 (es) Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
ES2171743T3 (es) Derivados de amidinas e isotioureas como inhibidores de la enzima sintasa de oxido nitrico.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
ES2074508T3 (es) Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos.
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
ES2169124T3 (es) Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
ES2148600T3 (es) Derivados de indol sustituidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 731099

Country of ref document: ES